NCT06204055

Brief Summary

The purpose of this study is to investigate specific clinical characteristics, amongst those with low back pain, that identify patient appropriateness for Intermuscular Dry-Needling (IMDN) and to develop a prediction tool that can be used by clinicians.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
85

participants targeted

Target at P50-P75 for not_applicable low-back-pain

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

January 2, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 12, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
Last Updated

January 12, 2024

Status Verified

January 1, 2024

Enrollment Period

7 months

First QC Date

January 2, 2024

Last Update Submit

January 11, 2024

Conditions

Keywords

Low Back PainDry-NeedlingMyofascial PainTreatment Based Classification

Outcome Measures

Primary Outcomes (1)

  • Oswestry Disability Index

    self reported questionnaire that is used to measure a patient's permanent functional disability.

    Baseline, week 1, week 2 and week 3

Secondary Outcomes (2)

  • Fear-Avoidance Beliefs Questionnaire

    Baseline, week 1, week 2 and week 3

  • 11 point Numeric Pain-Rating Scale

    Baseline, week 1, week 2 and week 3

Study Arms (2)

Intramuscular Dry-Needling

EXPERIMENTAL

(IMDN) is a minimally invasive procedure where a solid filament needle is inserted into a myofascial trigger point.

Other: Intramuscular Dry-Needling

Sham Intramuscular Dry-Needling

SHAM COMPARATOR

). Park sham acupuncture needles (AcuPrime) will be used to perform sham needling for this group. The sham needle functions by allowing the blunted needle to cause a pricking sensation when pushed against the skin, but does not penetrate. This will allow the patient to perceive that the needle is entering the skin while also maintaining therapist-patient contact and interaction time

Other: Intramuscular Dry-Needling

Interventions

It is a minimally invasive procedure where a solid filament needle is inserted deeply into a myofascial trigger point (MTrP) within a muscle in an attempt to abate it and illicit a desired treatment effect.

Intramuscular Dry-NeedlingSham Intramuscular Dry-Needling

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Males and females between the ages of 18 and 60 years with non-traumatic low back pain between the 12th rib and the buttock region.
  • Participants must also report an Oswestry Disability Index score of at least 20/100 points.

You may not qualify if:

  • Participants must be able to speak and read English.
  • Individuals who are currently pregnant, currently taking pain narcotic medication or have had a prior surgery in the lumbosacral spine
  • Those participants whose BMI is greater than 35

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Whitworth University

Spokane, Washington, 99251, United States

RECRUITING

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Dominic Severino, PT,DPT

    Whitworth University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dominic J Severino, PT,DPT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
After the physical examination has been performed, each participant will be randomized to receive IMDN or SIMDN. Randomization will be completed by use of a computer-generated list of random numbers that will designate group assignment. The PI will inform the study PTs of the participants group assignment. The list will be maintained by a research assistant who is not involved with participant recruitment, examination or treatment. Participants will be blinded to group assignment.
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: The first phase will be an RCT, 2 x 3 group (IMDN or Sham) by time (pretest, post-treatment week 1, post-treatment week 2, posttest, follow-up) with repeated measures on timeframe. The second phase will utilize logistic regression analysis to identify associations between the groups' demographic, historical, clinical variables and short-term pain and disability outcomes. This type of analysis will be able to identify strong predictors of the treatment outcome. Various processes will be used to determine optimal model fit for analysis.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

January 2, 2024

First Posted

January 12, 2024

Study Start

January 1, 2024

Primary Completion

August 1, 2024

Study Completion

November 1, 2024

Last Updated

January 12, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations